Status:
RECRUITING
An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Osteosarcoma
Eligibility:
All Genders
Brief Summary
The purpose of this study is to examine if we can predict sensitivity of osteosarcoma to different chemotherapy agents using tissue cultures in the laboratory. We know that different chemotherapy agen...
Detailed Description
Investigators successfully established a miniaturized system that allows the setup of hundreds of wells and perform assays with minimal manipulation. The adapted geometry used to plate tumor cells in ...
Eligibility Criteria
Inclusion
- Inclusion / exclusion criteria - Group1:
- \- Patients without diagnosis of osteosarcoma and whose imaging studies are suggestive of osteosarcoma and who are planned to undergo biopsy or surgery for diagnostic purposes
- Inclusion / exclusion criteria - Group 2:
- \- Patients whose imaging studies are suggestive of metastatic osteosarcoma and who are planned to undergo biopsy or surgery for diagnostic purposes
Exclusion
Key Trial Info
Start Date :
February 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06064682
Start Date
February 12 2024
End Date
January 1 2027
Last Update
July 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095